Adxto

Patient support

Enzyme support

Challenge: Studies show that only 30-50% comply with prescribed drug treatment. This may be due to ignorance, disease denial, misunderstanding, forgetfulness and decreased motivation over time. Customer wants to increase adherence to prescribed drug treatment of their product for patients diagnosed with endocrine pancreatic insufficiency to reduce gastrointestinal discomfort, increase QoL and increase dose.

Adxto's solution: The purpose of Adxto's digital Patient Support Programs is to create a bridge between healthcare and home care by providing additional support in the patient's home without the physical presence of healthcare professionals. The goal of the Patient Support Programs is to increase medication adherence through text messages, emails, data collection and nurse calls from Adxto. The pharmaceutical company sponsors the patient support program which is free of charge for the patient. The pharmaceutical company in turn receives the right statistics and information on how the medicine is working.

Results: Through targeted education, support and motivation, we have improved patient adherence to their prescription as there has generally been an increase in dose within the rec interval for all 140 patients in the program. In this way, we can obtain the optimal effect of the treatment and follow up the actual use and treatment from the patient's perspective. The result has been improved bowel habits and less stomach symptoms, being able to eat all the food, feeling more alert and better QoL. Patients have also experienced a sense of care and security. Want to know more? Contact Pontus

Adherence project KOL

Challenge: The aim of the project was to create and test a methodology and program to identify COPD patients and increase their adherence to the use of the customer's product. The goal was to include 80 newly diagnosed COPD patients, newly started on inhalation of the product.

Adxto's solution: Adxto created a program designed to support each individual patient for 12 months with the aim of increasing adherence by 30% units at the end of the program. This compared to a baseline where only 25% of COPD patients remain on the customer's product after 12 months. Adxto recruited patients in collaboration with doctors at health centers and screening days. Our specially trained nurse provided telephone support and assistance for one year to ensure patients used the product correctly, increase adherence and get patients to quit smoking for better QoL.

Results: Patients had an adherence rate of 80% at 6 months follow-up (previously 35%) and 75% at 18 months follow-up (previously 25%). Want to know more? Contact Johan

Patient voices from the project

  • "Positive feeling that someone cares"
  • "Good to be able to ask questions about the medicine in particular"
  • "I feel that I have experienced a bit of pressure regarding smoking, but I can recommend the support program."
  • "Good reminders about lifestyle changes"
  • "The support program would have been more useful to me if I had received it earlier in the course of my illness"

Scroll to the top

Stay updated and subscribe to our newsletter